| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |